{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:04:43Z","timestamp":1784167483033,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,15]]},"DOI":"10.7759\/cureus.112747","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:33:32Z","timestamp":1784165612000},"source":"Crossref","is-referenced-by-count":0,"title":["Demographic and Clinical Determinants of Acute Bronchiolitis Outcomes in a Tertiary Pediatric Hospital in Dubai, United Arab Emirates"],"prefix":"10.7759","author":[{"given":"Hadi","family":"Helali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshiya","family":"Hashmath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batool","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Mazahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2231","article-title":"Descriptive epidemiological features of bronchiolitis in a population-based cohort","volume":"122","author":"Koehoorn M","year":"2008","unstructured":"Koehoorn M, Karr CJ, Demers PA, Lencar C, Tamburic L, Brauer M. Descriptive epidemiological features of bronchiolitis in a population-based cohort. Pediatrics. 2008, 122:1196-203. 10.1542\/peds.2007-2231","journal-title":"Pediatrics"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li Y","year":"2022","unstructured":"Li Y, Wang X, Blau DM, et al.. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022, 399:2047-64. 10.1016\/S0140-6736(22)00478-0","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair H","year":"2010","unstructured":"Nair H, Nokes DJ, Gessner BD, et al.. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010, 375:1545-55. 10.1016\/S0140-6736(10)60206-1","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(22)01016-9","article-title":"Bronchiolitis","volume":"400","author":"Dalziel SR","year":"2022","unstructured":"Dalziel SR, Haskell L, O'Brien S, Borland ML, Plint AC, Babl FE, Oakley E. Bronchiolitis. Lancet. 2022, 400:392-406. 10.1016\/s0140-6736(22)01016-9","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.158.2.127","article-title":"Pharmacologic treatment of bronchiolitis in infants and children: a systematic review","volume":"158","author":"King VJ","year":"2004","unstructured":"King VJ, Viswanathan M, Bordley WC, Jackman AM, Sutton SF, Lohr KN, Carey TS. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med. 2004, 158:127-37. 10.1001\/archpedi.158.2.127","journal-title":"Arch Pediatr Adolesc Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2174\/1874285801408010071","article-title":"Respiratory syncytial virus infection in high-risk infants - an update on palivizumab prophylaxis","volume":"8","author":"Resch B","year":"2014","unstructured":"Resch B. Respiratory syncytial virus infection in high-risk infants - an update on palivizumab prophylaxis. Open Microbiol J. 2014, 8:71-7. 10.2174\/1874285801408010071","journal-title":"Open Microbiol J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040672","article-title":"Current state and challenges in developing respiratory syncytial virus vaccines","volume":"8","author":"Biagi C","year":"2020","unstructured":"Biagi C, Dondi A, Scarpini S, Rocca A, Vandini S, Poletti G, Lanari M. Current state and challenges in developing respiratory syncytial virus vaccines. Vaccines (Basel). 2020, 8:672. 10.3390\/vaccines8040672","journal-title":"Vaccines (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7241e1","article-title":"Use of the Pfizer respiratory syncytial virus vaccine during pregnancy for the prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants: recommendations of the Advisory Committee on Immunization Practices - United States, 2023","volume":"72","author":"Fleming-Dutra KE","year":"2023","unstructured":"Fleming-Dutra KE, Jones JM, Roper LE, et al.. Use of the Pfizer respiratory syncytial virus vaccine during pregnancy for the prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants: recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR Morb Mortal Wkly Rep. 2023, 72:1115-22. 10.15585\/mmwr.mm7241e1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7309a4","article-title":"Early estimate of nirsevimab effectiveness for prevention of respiratory syncytial virus-associated hospitalization among infants entering their first respiratory syncytial virus season - New Vaccine Surveillance Network, October 2023-February 2024","volume":"73","author":"Moline HL","year":"2024","unstructured":"Moline HL, Tannis A, Toepfer AP, et al.. Early estimate of nirsevimab effectiveness for prevention of respiratory syncytial virus-associated hospitalization among infants entering their first respiratory syncytial virus season - New Vaccine Surveillance Network, October 2023-February 2024. MMWR Morb Mortal Wkly Rep. 2024, 73:209-14. 10.15585\/mmwr.mm7309a4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri S","year":"2019","unstructured":"Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019, 13:S31-4. 10.4103\/sja.SJA_543_18","journal-title":"Saudi J Anaesth"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2023.113491","article-title":"Respiratory syncytial virus, influenza, and coronavirus disease 2019 hospitalizations in children in Colorado during the 2021-2022 respiratory virus season","volume":"260","author":"Rao S","year":"2023","unstructured":"Rao S, Armistead I, Tyler A, Lensing M, Dominguez SR, Alden NB. Respiratory syncytial virus, influenza, and coronavirus disease 2019 hospitalizations in children in Colorado during the 2021-2022 respiratory virus season. J Pediatr. 2023, 260:113491. 10.1016\/j.jpeds.2023.113491","journal-title":"J Pediatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2174\/1874306402115010007","article-title":"Epidemiology of bronchiolitis in hospitalized infants at Tawam Hospital, Al Ain, United Arab Emirates","volume":"15","author":"Al Shibli A","year":"2021","unstructured":"Al Shibli A, Nouredin MB, Al Amri A, Iram D, Narchi H. Epidemiology of bronchiolitis in hospitalized infants at Tawam Hospital, Al Ain, United Arab Emirates. Open Respir Med J. 2021, 15:7-13. 10.2174\/1874306402115010007","journal-title":"Open Respir Med J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2021.0295","article-title":"Effectiveness of targeted interventions on treatment of infants with bronchiolitis: a randomized clinical trial","volume":"175","author":"Haskell L","year":"2021","unstructured":"Haskell L, Tavender EJ, Wilson CL, et al.. Effectiveness of targeted interventions on treatment of infants with bronchiolitis: a randomized clinical trial. JAMA Pediatr. 2021, 175:797-806. 10.1001\/jamapediatrics.2021.0295","journal-title":"JAMA Pediatr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2021.5177","article-title":"Rates in bronchiolitis hospitalization, intensive care unit use, mortality, and costs from 2004 to 2018","volume":"176","author":"Mahant S","year":"2022","unstructured":"Mahant S, Parkin PC, Thavam T, et al.. Rates in bronchiolitis hospitalization, intensive care unit use, mortality, and costs from 2004 to 2018. JAMA Pediatr. 2022, 176:270-9. 10.1001\/jamapediatrics.2021.5177","journal-title":"JAMA Pediatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/510178-demographic-and-clinical-determinants-of-acute-bronchiolitis-outcomes-in-a-tertiary-pediatric-hospital-in-dubai-united-arab-emirates","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:33:33Z","timestamp":1784165613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/510178-demographic-and-clinical-determinants-of-acute-bronchiolitis-outcomes-in-a-tertiary-pediatric-hospital-in-dubai-united-arab-emirates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.112747","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,15]]}}}